SynthesisAnnals of medicine2023

Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients.

Bartosz Fialek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.